Skip to main content
. 2016 Nov 22;17:556. doi: 10.1186/s13063-016-1689-2

Table 1.

Summary of Pilot Trial outcomes

Pilot Trial outcomes Analysis Pass threshold
SQUEEZE
Primary outcomes
 1. Participant enrollment ratea
  Consent rate for continued participation
  Missed eligible patients
Simple proportion
Simple proportion
Simple proportion
≥2/month(/site)
Not applicable
Not applicable
 2. Protocol adherence: ability to initiate study procedures within 1 h of randomization Simple proportion Not applicable
Secondary outcomes
 1. Appropriateness of eligibility criteria as evidenced by the ability to identify and enroll participants in a timely manner Descriptive Not applicable
 2. Completeness of the clinical outcomes of interest to inform the design of the future multicenter trial Descriptive Not applicable
 3. We will also assess considerations related to study process, resource, and management aspects of feasibility Descriptive Not applicable
SQUEEZE-D
Primary outcome
 1. The proportion of SQUEEZE participants for whom cell-free deoxyribonucleic acid (cfDNA) can be described Simple proportion Not applicable
Secondary outcomes
 1. The availability of the required samples from patients enrolled into SQUEEZE and Simple proportion Not applicable
 2. We will also assess considerations related to study process, resource, and management aspects of feasibility which impact upon the ability to process and test samples to inform the design of a larger-scale study Descriptive Not applicable

aRecognizing that enrollment may be slower during the initial run-in phase